Upper respiratory tract infection (URTI) is a medical condition caused by acute infection that involves parts of the upper respiratory tract such as larynx or pharynx, sinuses, and nose.
Pharyngitis, sinusitis, laryngitis, tonsillitis, common cold, and otitis media are some of the most common upper respiratory tract disorders.
Some other symptoms of the disease are headaches, hyposmia, foul breath, sinus pain, shortness of breath, vomiting, diarrhea, nausea, conjunctivitis, and body ache.Read Report Overview - https://www.transparencymarketresearch.com/upper-respiratory-tract-infection-treatment-market.html Upper respiratory tract disorders can be treated with antibiotics and decongestants.
Antibiotics are rarely used as a treatment option for upper respiratory tract disorders as they are associated with many side effects and also can initiate secondary infections and bacterial resistance.
The global upper respiratory tract infection treatment market is expected to expand substantially, due to an increase in the incidence of respiratory disorders across the globe.
However, side effects of NSAIDs are expected to impact the growth of this market.
Upper respiratory tract infection (URTI) is a medical condition caused by acute infection that involves parts of the upper respiratory tract such as larynx or pharynx, sinuses, and nose.
Pharyngitis, sinusitis, laryngitis, tonsillitis, common cold, and otitis media are some of the most common upper respiratory tract disorders.
Some other symptoms of the disease are headaches, hyposmia, foul breath, sinus pain, shortness of breath, vomiting, diarrhea, nausea, conjunctivitis, and body ache.Read Report Overview - https://www.transparencymarketresearch.com/upper-respiratory-tract-infection-treatment-market.html Upper respiratory tract disorders can be treated with antibiotics and decongestants.
Antibiotics are rarely used as a treatment option for upper respiratory tract disorders as they are associated with many side effects and also can initiate secondary infections and bacterial resistance.
The global upper respiratory tract infection treatment market is expected to expand substantially, due to an increase in the incidence of respiratory disorders across the globe.
However, side effects of NSAIDs are expected to impact the growth of this market.